268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials

Affiliations

• ¹ Department of Neurology, Ludwig-Maximilian University Munich, Friedrich-Baur-Institute, Germany.
• ² Department of Neurology, The Royal Children's Hospital, Melbourne, Australia.
• ³ Department Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
• ⁴ Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
• ⁵ NIHR Biomedical Research Centre, University College London, Great Ormond Street Institute of Child Health and Great Ormond Street Hospital NHS Trust, United Kingdom of Great Britain and Northern Ireland, London WC1N 1EH, United Kingdom.
• ⁶ Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Nicol.Voermans@radboudumc.nl.
• ⁷ Unita Operativa Complessa di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
• ⁸ patient representative, Spain.
• ⁹ Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
• ¹⁰ Universite Cote d'Azur (UCA), Peripheral Nervous System, Muscle and ALS Department, Pasteur 2 Hospital, Nice; Universite Cote d'Azur, Inserm, CNRS, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.
• ¹¹ Friedrich-Baur Institute, Neurology Department, Ludwig-Maximilians University Munich, Germany.
• ¹² The Royal Children's Hospital and Murdoch Children's Research Institute, Melbourne, Australia.
• ¹³ Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
• ¹⁴ National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research center/University College London Great Ormond Street Institute of Child Health, London, UK.
• ¹⁵ Clinical Laboratory Geneticist, Biodonostia, San Sebastian, Spain.
• ¹⁶ Genomic Medicine Laboratory-UILDM, Santa Lucia Foundation IRCCS, Rome, Italy; Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
• ¹⁷ Clinical Laboratory Geneticist, Department of Clinical genetics, Leiden University Medical Center, Leiden, The Netherlands.
• ¹⁸ Clinical Laboratory Geneticist, North Bristol NHS Trust, Bristol, UK.
• ¹⁹ Aix Marseille Univ, INSERM, Marseille Medical Genetics, MMG, Marseille, France.
• ²⁰ Clinical Laboratory Geneticist, Human Genetics, UZ Leuven, Leuven, Belgium.
• ²¹ Patient Representative, FSHD Europe.
• ²² AFM-Telethon, France.
• ²³ Dept of Neurology, Koc University Medical Faculty, Koc University Hospital Muscle Center, I˙stanbul, Turkey.
• ²⁴ European Medicines Agency, Amsterdam, The Netherlands.
• ²⁵ Chief Science Officer, FSHD Society, USA.
• ²⁶ Reference center for Neuromuscular Diseases, Filnemus, Euro-NMD, University Hospital, CHU Nantes, Nantes, France.
• ²⁷ Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
• ²⁸ Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
• ²⁹ Professor emerita, Dept Medicine and Pharmacy, University of Mons, Mons, Belgium.